News Mendus AB

Equities

IMMU

SE0005003654

Market Closed - Nasdaq Stockholm Other stock markets 11:23:35 2024-04-26 am EDT			5-day change	1st Jan Change
0.4745 ^SEK	+0.96%		-5.10%	-9.27%

Apr. 16	Mendus AB Announces Board Changes	CI
Mar. 27	Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Mendus publishes Annual Report for 2023	Apr. 17	AQ
Notice of Annual General Meeting in Mendus AB (publ)	Apr. 16	AQ
Mendus AB Announces Board Changes	Apr. 16	CI
Mendus to participate in upcoming industry conferences	Apr. 08	AQ
Mendus raises approximately SEK 69.1 million through the warrants of series TO3	Apr. 02	AQ
Nomination committee proposes CMC specialist to Elicera's board of directors	Mar. 28	AQ
Mendus announces ethics committee approval for the AMLM22-CADENCE trial with lead product vididencel in AML	Mar. 27	AQ
Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML	Mar. 27	CI
Mendus to present NK cell program progress at the Innate Killer Summit	Mar. 19	GL
Mendus to present NK cell program progress at the Innate Killer Summit	Mar. 19	AQ
Mendus' : major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3	Mar. 15	PU
Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3	Mar. 15	GL
The exercise period for warrants of series TO3 commences today	Mar. 15	GL
The exercise period for warrants of series TO3 commences today	Mar. 15	AQ
Transcript : Mendus AB - Special Call	Mar. 12
Mendus provides business update and outlook for vididencel program	Mar. 12	GL
Mendus to participate in upcoming industry conferences	Feb. 27	GL
Mendus to participate in upcoming industry conferences	Feb. 27	AQ
Mendus to hold Business Update event on March 12	Feb. 23	GL
Mendus Q4 2023 - Gearing up for CADENCE	Feb. 14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Mendus AB

Equities

IMMU

SE0005003654

Summary

Filters